Aveanna Healthcare (AVAH) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue reached $559.2 million, up 14% year-over-year, with adjusted EBITDA of $67.4 million, a 93.1% increase, driven by improved pay rates, cost savings, and strong Private Duty Services (PDS) performance.

• Net income was $5.2 million, reversing a net loss of $11.2 million in Q1 2024, reflecting higher operating income and lower interest and tax expenses.

• Gross margin improved to $183.6 million (32.8% of revenue), up from $145.9 million (29.7%) last year, with field contribution margin rising to 16.5%.

• The acquisition of Thrive Skilled Pediatric Care was completed, expanding the pediatric care platform and presence in key states.

• Strategic focus on preferred payer agreements and government rate enhancements led to significant growth and improved caregiver hiring and retention.

Financial highlights

• All three operating divisions posted year-over-year revenue growth: PDS up 16.5% to $460 million, HHH up 3.9% to $56.7 million, and MS up 3.6% to $42.5 million.

• Gross margin was $183.6 million (32.8%), with adjusted EBITDA benefiting from $11 million in timing-related items and reserve improvements.

• Net income was $5.2 million, with adjusted net income of $21.4 million and adjusted EPS of $0.10.

• Q1 free cash flow was negative $12.9 million, reflecting typical seasonality, with liquidity of $266 million at quarter-end and cash of $71.5 million.

• Adjusted EBITDA was $67.4 million (12.0% of revenue), up from $34.9 million (7.1%) last year.

Outlook and guidance

• 2025 revenue is projected to exceed $2.15 billion, with adjusted EBITDA above $207 million, excluding the impact of the Thrive acquisition.

• Preferred payer agreements in PDS targeted to increase from 22 to 30 in 2025, with episodic mix in Home Health maintained above 70%.

• Volume growth in PDS expected to normalize to the higher end of the 3-5% range over the next quarters.

• Management expects continued growth driven by organic expansion and acquisitions, with sufficient liquidity to meet cash requirements for at least the next twelve months.

• No net income guidance due to volatility in certain inputs, including interest rate derivatives.